3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1/2
1
Status
Completed
3
Sponsor Class
NETWORK
6
OTHER
4
OTHER_GOV
3
NIH
3
Study Type
Interventional
3
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
13
Neoplasms
11
Breast Neoplasms
11
Carcinoma, Hepatocellular
10
Prostatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Stomach Neoplasms
5
Lung Neoplasms
5
Anastomotic Leak
5
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Stomatitis
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
HIV Infections
3
Disease
3
Depression
3
Vulvar Neoplasms
2
Surgical Wound Infection
2
Sleep Initiation and Maintenance Disorders
2
Skin Neoplasms
2
Sarcoma
2
Postoperative Complications
2
Peritoneal Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms, Plasma Cell
2
Neoplasm Metastasis
2
Motor Activity
2
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER_GOV
×
HIV Infections
×
90 days
×
Clear all
NCT01207986
2026-04-23
EP48 HIV CHEST
ANRS, Emerging Infectious Diseases
Phase NA
Completed
450 enrolled
NCT02287961
2026-04-23
APACHES
ANRS, Emerging Infectious Diseases
Phase NA
Completed
516 enrolled
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled